Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

M.V. Dieci; G. Bisagni; A.A. Brandes; A. Frassoldati; L. Cavanna; F. Giotta; M. Aieta; V. Gebbia; A. Musolino; O. Garrone; M. Donadio; A. Rimanti; A. Beano; C. Zamagni; H. Soto Parra; F. Piacentini; S. Danese; A. Ferro; K. Cagossi; S. Sarti; A.R. Gambaro; S. Romito; V. Bazan; L. Amaducci; G. Moretti; M.P. Foschini; S. Balduzzi; R. Vicini; R. D'Amico; G. Griguolo; V. Guarneri; P.F. Conte

doi:10.1186/s12916-019-1445-z

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

M.V. Dieci, G. Bisagni, A.A. Brandes, A. Frassoldati, L. Cavanna, F. Giotta, M. Aieta, V. Gebbia, A. Musolino, O. Garrone, M. Donadio, A. Rimanti, A. Beano, C. Zamagni, H. Soto Parra, F. Piacentini, S. Danese, A. Ferro, K. Cagossi, S. SartiA.R. Gambaro, S. Romito, V. Bazan, L. Amaducci, G. Moretti, M.P. Foschini, S. Balduzzi, R. Vicini, R. D'Amico, G. Griguolo, V. Guarneri, P.F. Conte

Research output: Contribution to journal › Article › peer-review

Original language	Italian
Journal	BMC Medicine
Volume	17
Issue number	1
DOIs	https://doi.org/10.1186/s12916-019-1445-z
Publication status	Published - 2019

Access to Document

10.1186/s12916-019-1445-z

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075456412&doi=10.1186%2fs12916-019-1445-z&partnerID=40&md5=916f318abfddcc718d870eeb1d9507c1

Cite this

Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., ... Conte, P. F. (2019). Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial. BMC Medicine, 17(1). https://doi.org/10.1186/s12916-019-1445-z

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial. / Dieci, M.V.; Bisagni, G.; Brandes, A.A.; Frassoldati, A.; Cavanna, L.; Giotta, F.; Aieta, M.; Gebbia, V.; Musolino, A.; Garrone, O.; Donadio, M.; Rimanti, A.; Beano, A.; Zamagni, C.; Soto Parra, H.; Piacentini, F.; Danese, S.; Ferro, A.; Cagossi, K.; Sarti, S.; Gambaro, A.R.; Romito, S.; Bazan, V.; Amaducci, L.; Moretti, G.; Foschini, M.P.; Balduzzi, S.; Vicini, R.; D'Amico, R.; Griguolo, G.; Guarneri, V.; Conte, P.F.

In: BMC Medicine, Vol. 17, No. 1, 2019.

Research output: Contribution to journal › Article › peer-review

Dieci, MV , Bisagni, G, Brandes, AA, Frassoldati, A, Cavanna, L, Giotta, F , Aieta, M, Gebbia, V, Musolino, A, Garrone, O, Donadio, M, Rimanti, A, Beano, A, Zamagni, C, Soto Parra, H, Piacentini, F, Danese, S, Ferro, A, Cagossi, K, Sarti, S, Gambaro, AR, Romito, S, Bazan, V, Amaducci, L, Moretti, G, Foschini, MP, Balduzzi, S, Vicini, R, D'Amico, R, Griguolo, G, Guarneri, V & Conte, PF 2019, 'Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial', BMC Medicine, vol. 17, no. 1. https://doi.org/10.1186/s12916-019-1445-z

Dieci, M.V. ; Bisagni, G. ; Brandes, A.A. ; Frassoldati, A. ; Cavanna, L. ; Giotta, F. ; Aieta, M. ; Gebbia, V. ; Musolino, A. ; Garrone, O. ; Donadio, M. ; Rimanti, A. ; Beano, A. ; Zamagni, C. ; Soto Parra, H. ; Piacentini, F. ; Danese, S. ; Ferro, A. ; Cagossi, K. ; Sarti, S. ; Gambaro, A.R. ; Romito, S. ; Bazan, V. ; Amaducci, L. ; Moretti, G. ; Foschini, M.P. ; Balduzzi, S. ; Vicini, R. ; D'Amico, R. ; Griguolo, G. ; Guarneri, V. ; Conte, P.F. / Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial. In: BMC Medicine. 2019 ; Vol. 17, No. 1.

@article{92fbef61affb46b591bbbc7621c634ef,

title = "Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial",

author = "M.V. Dieci and G. Bisagni and A.A. Brandes and A. Frassoldati and L. Cavanna and F. Giotta and M. Aieta and V. Gebbia and A. Musolino and O. Garrone and M. Donadio and A. Rimanti and A. Beano and C. Zamagni and {Soto Parra}, H. and F. Piacentini and S. Danese and A. Ferro and K. Cagossi and S. Sarti and A.R. Gambaro and S. Romito and V. Bazan and L. Amaducci and G. Moretti and M.P. Foschini and S. Balduzzi and R. Vicini and R. D'Amico and G. Griguolo and V. Guarneri and P.F. Conte",

note = "Export Date: 25 February 2020",

year = "2019",

doi = "10.1186/s12916-019-1445-z",

language = "Italian",

volume = "17",

journal = "BMC Medicine",

issn = "1741-7015",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

AU - Dieci, M.V.

AU - Bisagni, G.

AU - Brandes, A.A.

AU - Frassoldati, A.

AU - Cavanna, L.

AU - Giotta, F.

AU - Aieta, M.

AU - Gebbia, V.

AU - Musolino, A.

AU - Garrone, O.

AU - Donadio, M.

AU - Rimanti, A.

AU - Beano, A.

AU - Zamagni, C.

AU - Soto Parra, H.

AU - Piacentini, F.

AU - Danese, S.

AU - Ferro, A.

AU - Cagossi, K.

AU - Sarti, S.

AU - Gambaro, A.R.

AU - Romito, S.

AU - Bazan, V.

AU - Amaducci, L.

AU - Moretti, G.

AU - Foschini, M.P.

AU - Balduzzi, S.

AU - Vicini, R.

AU - D'Amico, R.

AU - Griguolo, G.

AU - Guarneri, V.

AU - Conte, P.F.

N1 - Export Date: 25 February 2020

PY - 2019

Y1 - 2019

U2 - 10.1186/s12916-019-1445-z

DO - 10.1186/s12916-019-1445-z

M3 - Articolo

VL - 17

JO - BMC Medicine

JF - BMC Medicine

SN - 1741-7015

IS - 1

ER -